BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioInvest

Merck Group Announces Acquisition of UnitySC for €155 Million

This strategic acquisition is a significant milestone in Merck’s Electronics business, aimed at expanding its capabilities and strengthening ...

July 18, 2024 | News

Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.

Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manuf...

June 25, 2024 | News

Ascentage Pharma Announces Completion of Equity Investment by Takeda

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related...

June 21, 2024 | News

HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology

Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...

May 29, 2024 | News

AstraZeneca Announces $1.5 Billion Manufacturing Facility in Singapore for Cutting-Edge Cancer Treatments

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global s...

May 20, 2024 | News

Nabla Bio Secures $26 Million Series A and $550 Million in Strategic Pharma Collaborations

➢ Company builds integrated AI and wet lab technologies to design developable, selective, and functionally active protein drugs against ...

May 15, 2024 | News

Allozymes Secures $15 Million Series A Funding to Transform Enzyme Engineering and Expand Global Presence

Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a $15 million Series A funding round led by Se...

May 15, 2024 | News

NSG BioLabs Secures $14.5 Million Investment, Expands Partnerships to Bolster Singapore's Biotech Ecosystem

NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investme...

May 08, 2024 | News

Gilead Sciences Invests US$4 Million in Global Fight Against Viral Hepatitis

Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant World Hepatitis Allianc...

April 16, 2024 | News

D3 Bio Secures $62M in Series A+ Financing for Cancer Drug Development

D3 Bio, an emerging global biotechnology company that focuses on discovery, development, and registration of innovative cancer drugs announces its cl...

April 09, 2024 | News

Johnson & Johnson Completes $2 Billion Acquisition of Ambrx Biopharma, Bolstering Oncology Pipeline

Johnson & Johnson (NYSE: JNJ) announced it has successfully completed the acquisition of Ambrx Biopharma, Inc., a clinical-stage biopharmaceutica...

March 08, 2024 | News

Merck Opens new € 20 Million Distribution Center in Brazil

New site in Cajamar, São Paulo has 2.5 times more storage capacity than previous space in Cotia, São Paulo 13,000 square-meters space for ...

March 04, 2024 | News

Cure Brain Cancer Foundation CEO Lance Kawaguchi Triumphs in SouthPoleTrek4Cancer, Raising Over $1 Million

Lance Kawaguchi, the dynamic CEO of Cure Brain Cancer Foundation, has achieved an extraordinary milestone by ...

February 26, 2024 | News

BioAge Secures $170 Million in Series D Funding to Propel Obesity and Metabolic Disease Drug Development

BioAge Labs (“BioAge”), a pioneering biotechnology firm dedicated to advancing novel treatments for obesity and metabolic diseases by e...

February 14, 2024 | News

Stay Connected